Offner F A, Schäfer G, Hittmair A, Ofner D, Grünewald K, Weyrer K, Mattern D, Eberle J, Mikuz G, Feichtinger H
Institut für Pathologische Anatomie, Universität Innsbruck.
Verh Dtsch Ges Pathol. 1993;77:241-6.
Mutations of the p53 gene are important mechanisms in malignant transformation and are associated with dysregulation of normal cell growth. In the present study the expression of mutated p53-protein and proliferating cell nuclear antigen (PCNA) was investigated in a series of 31 human transitional cell carcinomas (TCC) by immunohistochemistry (IHC). The number of PCNA-positive cells and the pattern of expression was distinct in normal urothelium being confined to the basal cell layer. In dysplastic urothelium and in Carcinoma in situ (CIS) PCNA-immunoreactive nuclei were irregularly distributed throughout all layers. In tumor cell complexes the pattern of PCNA-immunoreactivity was different in papillary and primary infiltrating TCCs. Densitometric quantification of the intensity of the PCNA-reactivity using image analysis revealed an increase from normal to dysplastic urothelium and from dysplastic urothelium to invasive tumors. 21/31 (68%) of the tumors and tumor-associated CIS showed overexpression of p53 varying in percentage, pattern and reaction intensity. The percentage of PCNA-positive cells was higher in tumors overexpressing p53. Double IHC showed colocalization of both molecules in a significant proportion of tumor cells suggesting a link of p53 overexpression and the abnormal proliferative activity. The present results show that p53 over-expression is found in a significant percentage of TCCs and indicate a close association with a defective growth regulation resulting in increased PCNA-levels and enhanced cellular proliferation.
p53基因的突变是恶性转化的重要机制,与正常细胞生长的失调有关。在本研究中,通过免疫组织化学(IHC)对31例人类移行细胞癌(TCC)进行了突变型p53蛋白和增殖细胞核抗原(PCNA)表达的研究。正常尿路上皮中PCNA阳性细胞的数量和表达模式不同,仅限于基底细胞层。在发育异常的尿路上皮和原位癌(CIS)中,PCNA免疫反应性细胞核不规则地分布于所有层。在肿瘤细胞复合体中,PCNA免疫反应性模式在乳头状和原发性浸润性TCC中有所不同。使用图像分析对PCNA反应强度进行光密度定量分析显示,从正常尿路上皮到发育异常的尿路上皮,再到浸润性肿瘤,其强度逐渐增加。31例肿瘤中有21例(68%)以及肿瘤相关的CIS显示p53过度表达,其百分比、模式和反应强度各不相同。p53过度表达的肿瘤中PCNA阳性细胞的百分比更高。双重免疫组织化学显示,在相当比例的肿瘤细胞中这两种分子共定位,提示p53过度表达与异常增殖活性之间存在联系。目前的结果表明,在相当比例的TCC中发现了p53过度表达,并且表明其与生长调节缺陷密切相关,导致PCNA水平升高和细胞增殖增强。